Skip to main content
Caplight Logo









Craniometrix

Craniometrix

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.craniometrix.com/

Last Round

Series A

Mar 30, 2026

Est. Valuation

$21M

Total Funding Raised

$51.5M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Craniometrix is a healthcare technology company that provides an AI-powered care navigation platform for Alzheimer's and dementia patients and their caregivers.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Clinical Trials, Vertical SaaS

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

dementia carecognitive assessmentneuro-diagnostic softwarecare navigationMedicare GUIDE programcaregiver supporthealthtechvertical SaaSclinical workflow automationneurological data analysisAI care coordinationremote patient monitoringRPMdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Craniometrix Comparables

Compare Craniometrix with similar companies based on industry and business-model similarity.

Craniometrix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Altoida, Inc.
87%
Linus Health
81%
BrainCheck
79%

Craniometrix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 30, 2026
Series AFeb 27, 2026
Series AJan 1, 2026
SeedAug 10, 2022
AcceleratorMar 1, 2022

Craniometrix Investors

Notable investors and investment history

Craniometrix investors
InvestorRounds
J VenturesSeries A, Seed
Defy Partners ManagementSeries A, Seed
AGI HouseSeries A
Y CombinatorSeries A, Seed, Accelerator
Cathexis VenturesSeries A, Seed
Rebel FundSeries A, Seed
Quiet CapitalSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 44% MoM.

  • Jul 23, 2026

    Reached $8M in Annual Recurring Revenue in its first year.

Craniometrix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Craniometrix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Craniometrix's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range34
Year Founded2022
Last FundingMar 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?